Back to photostream

Alzheimers-Disease-market-analysis

The Puzzle Of So-Called Alzheimer’s

As per Alzheimer's Association®, more than 5 million people in the #US alone are living with #Alzheimer’s, and by 2050, the prevalence is projected to propel to nearly 14 million people. Being the 6th leading cause of death in the US, #AlzheimersDisease is the cause of more deaths than #ProstateCancer and #Breastcancer combined.

 

Some of the key players in the Alzheimer’s Disease Market at global level includes Neurotrope Bioscience, Inc. Amarantus BioScience, AgeneBio, Novartis, Cortexyme, Inc., TauRx Therapeutics Ltd., Otsuka Pharmaceutical Companies (U.S.), AC Immune, Genentech, Alkahest, Inc., Cerecin, vTv Therapeutics LLC and others.

 

For more details visit: www.delveinsight.com/blog/alzheimers-disease-market/

 

#MemoryLoss #Dementia #NeurodegenerativeDisease #Market #BrainDisease #AlzheimerDisease #Healthcare #Lifesciences #Biotechnology #Pharmaceuticals #NeurologicalDisorder #Marketresearch

 

41 views
0 faves
0 comments
Uploaded on June 16, 2020